Results
1
Undervalued Small Caps
1 companies
Zevra Therapeutics
Market Cap: US$715.0m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.74
7D
-3.2%
1Y
25.4%
